stockrow
Saturday 7 November 2026
Export HYFT’s income statement to Excel — free account
MindWalk Holdings Corp.
HYFT Healthcare Biotechnology
MindWalk Holdings Corp.’s revenue for fiscal 2026 (year ended April 2026) was $11.3 million, down 35.9% from fiscal 2025.
- Revenue
- +19.4%
- EPS
- −80.0%
- Free cash flow
- +9.79%
- Total debt
- −10.8%
Quarter to July 2026, against a year earlier
1.05
0.05
+5.00%
Follow HYFT
Alert me
| Apr '26 | Apr '25 | Apr '24 | Apr '23 | Apr '22 | Apr '21 | Apr '20 | Apr '19 | Apr '18 | Apr '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
6 | 4 | 2 | 1 | 2 | 4 | 4 | — | — | — |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
4.90 | 0.84 | 1.81 | 4.12 | 7.05 | 12.29 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(5.59) | (3.57) | (1.62) | 0.46 | 3.82 | 12.63 | 1.94 | — | 1.25 | — |
Altman Z″-Score (non-manufacturers) |
(21.98) | (8.69) | (5.29) | (1.58) | 3.53 | 7.99 | (3.54) | — | (2.66) | — |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
(3.70) | (5.41) | (4.45) | (2.84) | (2.12) | (3.37) | — | — | — | — |
P/Operating CF |
(31.03) | (16.45) | (16.76) | (34.52) | (73.18) | (369.03) | 0.00 | 0.00 | 0.00 | 0.00 |
P/B ratio |
6.48 | 0.87 | 1.31 | 1.47 | 1.81 | 3.89 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
29.95 | 1.43 | 16.55 | 11.03 | 5.89 | 5.14 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
4.56 | 1.00 | 2.19 | 4.05 | 5.59 | 10.16 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 46.52 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(5.70) | (3.82) | (12.63) | (4.22) | (10.91) | (365.48) | 0.00 | 0.00 | 0.00 | 0.00 |
EV/FCF |
(5.52) | (3.40) | (9.50) | (3.93) | (9.86) | (365.48) | 0.00 | 0.00 | 0.00 | 0.00 |
Quick Ratio |
2.48 | 1.66 | 0.94 | 2.04 | 3.54 | 7.43 | 0.80 | 1.03 | 0.94 | 3.71 |
Current Ratio |
2.80 | 2.08 | 1.41 | 2.84 | 4.05 | 8.05 | 0.97 | 1.19 | 1.12 | 3.92 |
Net Debt/EBITDA |
0.62 | (0.12) | (1.04) | 0.10 | 2.27 | 11.41 | (2.67) | 0.63 | (0.46) | 2.00 |
Debt/Assets |
14.36% | 26.00% | 20.20% | 7.90% | 1.77% | 4.96% | 16.54% | 10.28% | 15.54% | 0.00% |
Debt/Equity |
0.26 | 0.49 | 0.36 | 0.11 | 0.02 | 0.06 | 0.30 | 0.16 | 0.30 | 0.00 |
Asset Turnover |
0.48 | 0.46 | 0.35 | 0.23 | 0.25 | 0.42 | 0.51 | 0.40 | 0.44 | 301.93 |
Operating CF/Net income |
0.89 | 0.21 | 0.16 | 0.75 | 0.59 | 0.08 | 0.28 | 0.42 | 0.66 | 0.14 |
Capex/Depreciation |
(0.25) | (0.16) | (0.24) | (0.22) | (0.33) | (0.37) | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
— | (43.72) | — | — | (48.65) | (13.70) | (8.40) | 0.00 | (60.92) | 0.00 |
| (79.38%) | (103.12%) | (58.67%) | (38.62%) | (25.72%) | (21.87%) | (29.87%) | (48.75%) | (63.01%) | (381.82%) | |
| (42.67%) | (56.85%) | (39.09%) | (30.03%) | (21.18%) | (17.19%) | (17.81%) | (28.16%) | (42.17%) | (61,796.48%) | |
ROIC |
(269.05%) | (31.55%) | (20.69%) | (32.05%) | (21.62%) | (23.94%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(96.35%) | (118.55%) | (135.48%) | (124.91%) | (52.97%) | (15.68%) | (175.20%) | (260.11%) | (249.36%) | (174.11%) |
Average Days of Receivables |
70.40 | 63.38 | 62.59 | 66.82 | 52.40 | 68.24 | 93.63 | 63.84 | 148.56 | 73.62 |
Research and Development Expense of Revenue |
31.71% | 20.16% | 16.49% | 59.42% | 34.56% | 11.02% | 3.17% | 4.45% | 9.36% | 25.11% |
Selling, General and Administrative Expense of Revenue |
123.10% | 77.62% | 78.04% | 113.33% | 59.75% | 58.52% | 22.04% | 35.62% | 54.81% | 53.22% |
Intangible Assets out of Total Assets |
0.00 | 0.21 | 0.52 | 0.64 | 0.56 | 0.21 | 0.59 | 0.64 | 0.36 | 0.00 |
Share Based Compensation of Revenue |
8.20% | 1.81% | 6.26% | 9.40% | 15.92% | 15.34% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.09 | (0.10) | (0.33) | (0.04) | 0.14 | 0.18 | 0.00 | 0.00 | 0.00 | 0.00 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(18.49%) | (154.55%) | (60.94%) | (31.91%) | (12.30%) | (3.53%) | (1.79%) | (1.79%) | (1.79%) | (1.79%) |
Free Cash Flow Yield |
(16.88%) | (35.21%) | (12.74%) | (25.08%) | (8.04%) | (0.23%) | 0.00% | 0.00% | 0.00% | 0.00% |
Revenue per Share |
0.24 | 0.53 | 0.71 | 0.62 | 0.78 | 0.83 | 0.56 | 0.49 | 0.36 | 0.49 |
Operating CF per Share |
(0.19) | (0.14) | (0.12) | (0.60) | (0.40) | (0.03) | (0.05) | (0.14) | (0.23) | (0.14) |
Capex per Share |
(0.01) | (0.02) | (0.04) | (0.05) | (0.05) | (0.06) | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(0.20) | (0.15) | (0.16) | (0.64) | (0.45) | (0.09) | (0.05) | (0.14) | (0.23) | (0.14) |
Cash per Share |
0.18 | 0.23 | 0.10 | 0.25 | 1.21 | 1.94 | 0.10 | 0.24 | 0.12 | 0.48 |
Shareholders Equity per Share |
0.18 | 0.51 | 0.98 | 1.75 | 3.05 | 2.64 | 0.57 | 0.80 | 0.84 | 0.57 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.18 | 0.51 | 0.98 | 1.75 | 3.05 | 2.64 | 0.57 | 0.80 | 0.84 | 0.57 |
Free Cash Flow |
(9.32) | (5.17) | (4.18) | (16.05) | (8.91) | (1.51) | (0.75) | (1.82) | (2.07) | (0.55) |
Working Capital |
7.56 | 6.99 | 2.49 | 8.18 | 22.48 | 32.74 | (0.12) | 0.75 | 0.30 | 1.80 |
Capital Expenditures |
(0.29) | (0.57) | (1.03) | (1.12) | (1.00) | (1.05) | (0.31) | (0.37) | (0.21) | (0.39) |
Net Current Asset Value |
4.78 | (1.48) | (10.80) | (2.42) | 15.35 | 29.70 | (2.32) | (1.02) | (4.29) | 1.80 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.03 | 0.03 | 0.06 | 0.07 | 0.06 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.40 | 0.32 | 0.34 | 0.64 | 1.13 | 0.92 | 1.12 | 1.41 | 0.29 | 0.08 |
Cash ROIC |
(49.15%) | (15.73%) | (11.40%) | (29.53%) | (10.46%) | (1.94%) | (6.51%) | (12.37%) | (18.69%) | (13.31%) |
Accounts Receivable Turnover |
4.31 | 5.70 | 6.09 | 6.14 | 6.46 | 6.09 | 5.01 | 5.10 | 3.81 | 9.90 |
Accounts Payable Turnover |
1.36 | 2.24 | 3.19 | 2.16 | 2.19 | 3.25 | 9.92 | 6.84 | 4.77 | 1.37 |
Inventory Turnover |
5.00 | 5.10 | 5.89 | 4.83 | 6.05 | 7.25 | 18.13 | 20.89 | 27.89 | 7.75 |
Average Days of Payables |
237.91 | 175.75 | 128.02 | 135.78 | 207.65 | 172.42 | 32.54 | 44.59 | 110.27 | 124.19 |
Days of Inventory on Hand |
28.02 | 69.70 | 62.63 | 82.61 | 70.33 | 68.95 | 19.68 | 22.37 | 22.33 | 11.17 |
Average Receivables |
2.61 | 3.08 | 2.98 | 2.53 | 2.39 | 2.25 | 1.51 | 1.21 | 0.87 | 0.20 |
Average Payables |
3.41 | 3.51 | 2.89 | 3.17 | 3.05 | 1.50 | 0.79 | 1.06 | 0.86 | 1.03 |
Average Inventory |
0.93 | 1.54 | 1.57 | 1.42 | 1.10 | 0.67 | 0.43 | 0.35 | 0.15 | 0.18 |
Average Assets |
23.69 | 38.16 | 51.49 | 66.54 | 62.88 | 32.68 | 14.96 | 15.33 | 7.44 | 0.01 |
Average Common Equity |
12.73 | 21.04 | 34.31 | 51.75 | 51.78 | 25.68 | 8.92 | 8.85 | 4.98 | 1.04 |
Columns are period end dates · fundamentals updated 2 Oct 2026